
<PAGE>
<PAGE>   1
                                  UNITED STATES
                        SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C. 20549

                                   SCHEDULE 13D

                  Under the Securities and Exchange Act of 1934
                               (Amendment No.   )*

                  Ameriwood Industries International Corporation
-------------------------------------------------------------------------------
                                 (Name of Issuer)

                              Shares of Common Stock
-------------------------------------------------------------------------------
                          (Title of Class of Securities)

                                   03070M-10-0
-------------------------------------------------------------------------------
                                  (CUSIP Number)

                 Marc C. Krantz, Kohrman Jackson & Krantz P.L.L.,
            1375 East 9th Street, Cleveland, Ohio 44114, 216-736-7204
-------------------------------------------------------------------------------
             (Name, Address and Telephone Number of Person Authorized
                      to Receive Notices and Communications)

                                 October 7, 1997
-------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].

Note:  Six copies of this statement, including all exhibits, should be filed
with the Commission.  See Rule 13d-1(a) for other parties to whom copies are to
be sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>
<PAGE>   2
<TABLE>
                                   SCHEDULE 13D
CUSIP NO. 03070M-10-0
<S>  <C>
-------------------------------------------------------------------------------
1    NAME OF REPORTING PERSON
     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
     Turkey Vulture Fund XIII, Ltd.
-------------------------------------------------------------------------------
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                 (a) [x]
                                                                       (b) [ ]
-------------------------------------------------------------------------------
3    SEC USE ONLY

-------------------------------------------------------------------------------
4    SOURCE OF FUNDS*
     WC,OO
-------------------------------------------------------------------------------
5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
     TO ITEMS 2(d) or 2(e)                                                 [ ]
-------------------------------------------------------------------------------
6    CITIZENSHIP OR PLACE OF ORGANIZATION
     Ohio
-------------------------------------------------------------------------------
       NUMBER OF         7    SOLE VOTING POWER

        SHARES                221,500
                         ------------------------------------------------------
     BENEFICIALLY        8    SHARED VOTING POWER

       OWNED BY               
                         ------------------------------------------------------
         EACH            9    SOLE DISPOSITIVE POWER

      REPORTING               221,500
                         ------------------------------------------------------
        PERSON           10   SHARED DISPOSITIVE POWER

         WITH
-------------------------------------------------------------------------------
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     221,500
-------------------------------------------------------------------------------
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*[ ]
-------------------------------------------------------------------------------
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     5.2%
-------------------------------------------------------------------------------
14   TYPE OF REPORTING PERSON*
     OO
-------------------------------------------------------------------------------
</TABLE>
<PAGE>
<PAGE>   3
CUSIP No. 03070M-10-0

     This original Schedule 13D Statement is filed on behalf of Turkey Vulture
Fund XIII, Ltd., an Ohio limited liability company (the "Fund"), for the
purpose of reporting certain acquisitions of shares of common stock, par value
$1.00 per share, of Ameriwood Industries International Corporation, a Michigan
corporation.

Item 1.   Security and Issuer.

     This Schedule 13D Statement relates to the shares of common stock, par
value $1.00 per share (the "Shares"), of Ameriwood Industries International
Corporation, a Michigan corporation ("Ameriwood"), which has its principal
executive offices at 171 Monroe Avenue N.W., Suite 600, Grand Rapids, Michigan
49503.  

Item 2.   Identity and Background.

     (a)  The person filing this Schedule 13D is Turkey Vulture Fund XIII,
Ltd., an Ohio limited liability company.  Richard M. Osborne is the sole
manager of the Fund.

     (b)  The address of the Fund, and the business address of Mr. Osborne, is
7001 Center Street, Mentor, Ohio 44060.

     (c)  The principal business of the Fund is to acquire, hold, sell or
otherwise invest in all types of securities and other instruments.   Mr.
Osborne's principal occupation is President and Chairman of the Board of OsAir,
Inc., a property developer and manufacturer of industrial gases for pipeline
delivery.  OsAir, Inc. is located at 7001 Center Street, Mentor, Ohio 44060.

     (d)  Negative with respect to the Fund and Mr. Osborne.

     (e)  Negative with respect to the Fund and Mr. Osborne.

     (f)  The Fund is a limited liability company organized under the laws of
the state of Ohio.   Mr. Osborne is a citizen of the United States of America.

Item 3.   Source and Amount of Funds or Other Consideration.

     The Shares reported herein as having been acquired by the Fund were
acquired for the aggregate purchase price of approximately $1.5 million with a
combination of working capital of the Fund and margin debt from Everen
Securities, Inc. ("Everen").  

     Interest on the Everen margin debt is computed at a select rate above the
rate banks charge securities brokers ("brokers call money rate") and is subject
to change, without notice, if the brokers call money rate changes.  To the
<PAGE>
<PAGE>   2
CUSIP No. 03070M-10-0

extent permitted by law, Everen has a lien on certain of the Shares reported
herein as having been acquired by the Fund and the Trust.  A copy of the
agreement setting forth the terms of the Fund's Everen margin debt is attached
hereto as Exhibit 7.1.
 
Item 4.   Purpose of Transaction.

     The Fund purchased the Shares to acquire a minority interest in Ameriwood
for the purposes of investment.   Depending on market conditions, developments
with respect to Ameriwood's business and other factors, the Fund and Mr.
Osborne reserve the right to dispose of or acquire additional Shares.  

     Pursuant to the instructions for items (a) through (j) of Item 4 of
Schedule 13D, neither the Fund nor Mr. Osborne presently has plans or proposals
that relate to or would result in any of the following:

     (i)  an extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving Ameriwood or any of its subsidiaries;

     (ii) the sale or transfer of a material amount of assets of Ameriwood or
any of its subsidiaries;

     (iii)any change in the present board of directors or management of
Ameriwood, including any plans or proposals to change the number or terms of
directors or to fill any existing vacancies on the board;

     (iv) a material change in the present capitalization or dividend policy of
Ameriwood;

     (v)  a material change in the business or corporate structure of
Ameriwood;

     (vi) a change to the Articles of Incorporation or Bylaws of Ameriwood or
an impediment to the acquisition of control of Ameriwood by any person;

     (vii)the delisting from the National Association of Securities Dealers
Automated Quotation System of the Shares;
     
     (viii)a class of equity securities of Ameriwood becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"); or
     
     (ix) any action similar to any of those enumerated in (i) through (viii)
above.

<PAGE>
<PAGE>   3
CUSIP No. 03070M-10-0

     Mr. Osborne and the Fund reserve the right to modify their plans and
proposals described in this Item 4.  Further, subject to applicable laws and
regulations, they may formulate plans and proposals that may result in the
occurrence of an event set forth in (i) through (ix) above or in Item 4 of
Schedule 13D.

Item 5.   Interest in Securities of the Issuer.

     (a)  According to the most recently available filing with the Securities
and Exchange Commission by Ameriwood, there are 4,259,406 Shares outstanding.  

     The Fund beneficially owns 221,500 Shares, or approximately 5.2% of  the
outstanding Shares.  As sole Manager of the Fund, Mr. Osborne may be deemed to
beneficially own all such Shares. 

     (b)  Mr. Osborne, as sole Manager of the Fund, has sole power to vote, or
to direct the voting of, and the sole power to dispose or to direct the
disposition of, the Shares owned by the Fund. 

     (c)  During the past 60 days, the Fund purchased 221,500 Shares in open
market transactions as set forth below:

<TABLE>
                                             Approximate Per Share Price
            Date          Number of Shares     (Excluding Commissions)
     ------------------   ----------------   ---------------------------
     <S>                  <C>                <C>   
     September 19, 1997        8,000                   $6.00
     September 22, 1997       25,000                   $5.94
     September 23, 1997       35,000                   $6.14
     September 26, 1997        1,000                   $6.63
     September 29, 1997        7,500                   $6.75
     October 6, 1997          45,000                   $6.81
     October 7, 1997         100,000                   $6.81
</TABLE>
                    
     (d)  Not Applicable.

     (e)  Not Applicable.


Item 6.   Contracts, Arrangements, Understandings or Relationships With Respect
to Securities of the Issuer.

     Not Applicable.

<PAGE>
<PAGE>   4
CUSIP No. 03070M-10-0
     
Item 7.   Material to be Filed as Exhibits.

     Exhibit 7.1    General Account Agreement Letter to Kemper Securities, Inc.
                    (predecessor-in-interest to Everen) from Turkey Vulture
                    Fund XIII, Ltd.


<PAGE>
<PAGE>   5
CUSIP No. 03070-10-0

     After reasonable inquiry and to the best of my knowledge and belief, I

certify that the information set forth in this statement is true, complete and

correct.



Dated: October 13, 1997            TURKEY VULTURE FUND XIII, LTD.


                                   By: /s/ Richard M. Osborne
                                      ---------------------------
                                      Richard M. Osborne, Manager





<PAGE>
<PAGE>   6
CUSIP NO. 03070M-10-0

                                  Exhibit Index

     
Exhibit 7.1    General Account Agreement Letter to Kemper Securities, Inc.
               (predecessor-in-interest to Everen) from Turkey Vulture Fund
               XIII, Ltd.


